Michael Schultheiß

机构：University of Freiburg, University Medical Center Freiburg · ORCID：0000-0001-8000-1721

发表论文 196 篇 · 总被引 3118 次 · h-index 29

代表论文

• Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma (2024 · Gut · 被引 61)
• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)
• Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort (2024 · Hepatology Communications · 被引 14)
• Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPS (2025 · Journal of Hepatology · 被引 13)
• Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation (2025 · JHEP Reports · 被引 11)
• Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort Study (2025 · Clinical Gastroenterology and Hepatology · 被引 11)